SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Celgene-CELG
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
804 71 0 CELG
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
704$100M market cap to s&p 500 in 10 years, it can happen!rkrw-10/30/2006
703CELG to be added to the S&P 500 Standard & Poor's Announces Changessim1-10/30/2006
702Merrill: Celgene encouraged by Revlimid launch Key takeaways from Celgene’s prtom pope-9/21/2006
701Jim’s (rkrw) story about Thalidomide is bit short. At the time CELG obtained ThaMiljenko Zuanic-9/11/2006
700I appreciate your help. But how did Thalomid become the de facto standard of caLhn5-9/11/2006
699Celg got thalidomide approved in leprosy only, analyst estimates assumed a peak rkrw-9/11/2006
698I don't know if anyone is intimately familiar with CELG fundamentals, but I Lhn5-9/11/2006
697Merrill: Thalomid NDC weekly sales data ahead of 3Q estimates NDC weekly data ftom pope-9/6/2006
696After Years Of Hard Times, Celgene's Patience Pays Off Monday July 3, 7:00 psim1-7/3/2006
695Merrill: Celgene Corporation (CELG; $47.23; C-1-9) Reiterate Buy on Revlimid Aptom pope-6/30/2006
694REVLIMID(R) in Combination With Dexamethasone sNDA Granted Approval By FDA for Tsim1-6/29/2006
693Celgene's Revlimid Could See European Pricing Upside: Report Peter Kang, 06.sim1-6/27/2006
692ML: More Positive ASCO updates for Revlimid, Thalomid in MM Additional updates tom pope-6/6/2006
691Celgene's Front and Center at ASCO By Althea Chang TheStreet.com Staff RepoDoc Bones-6/6/2006
690125 REASONS TO OWN CELGENE Rob_Cos/JBWIN416 1) Already solidly profitable for 1rolatzi-5/24/2006
689Celgene Cellular Therapeutics Strengthens Intellectual Property Estate in the Fisim1-5/16/2006
688Message 22412392 [Jim Cramer]Doc Bones-5/3/2006
687Celgene Corporation Reports Record Revenue and Operating Profits Thursday AprilDoc Bones-4/27/2006
686Celgene posts lower 1st-quarter profit, revs jump Thu Apr 27, 2006 8:06 AM ET Doc Bones-4/27/2006
685Celgene Might Be Trouble for Millennium By Althea Chang TheStreet.com Staff Repsim1-4/26/2006
684LifebankUSA(TM) Announces New Service to Bank Placental-Derived Stem Cells Tuesdsim1-4/18/2006
683Can Celgene Stock's Torrid Pace Endure? [WSJ] Pressure on High Costs of CanDoc Bones-4/6/2006
682Thalidomide, Lenalidomide Show Promise Against Lou Gehrig's Disease Source:sim1-3/10/2006
681Study: Thalidomide boosts short-term survival in multiple myeloma patients By sim1-3/10/2006
680Thalidomide Proves Ineffective Against Bone-Marrow Cancer Associated Press MarcDoc Bones-3/9/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News